SCHEMBL9163894

SCHEMBL9163894

O=C/C=C/c1cc(O)cc(O)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNB2 O95067 1/20 0.63
▸ CDK1 P06493 1/20 0.63
▸ CDK4 P11802 1/20 0.63
▸ CCNB1 P14635 1/20 0.63
▸ CCND1 P24385 1/20 0.63
▸ CCNB3 Q8WWL7 1/20 0.63
▸ LCK P06239 3/20 0.62
▸ ALDH1A1 P00352 5/20 0.60
▸ KDM4E B2RXH2 4/20 0.60
▸ MAPT P10636 4/20 0.60
▸ XDH P47989 2/20 0.54
▸ GABBR2 O75899 1/20 0.53
▸ GABBR1 Q9UBS5 1/20 0.53
▸ LMNA P02545 4/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ TP53 P04637 3/20 0.50
▸ CYP1A2 P05177 3/20 0.50
▸ CYP3A4 P08684 3/20 0.50
▸ CYP2C9 P11712 3/20 0.50
▸ HPGD P15428 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5849926 0.78 XDH (0.63) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL720795 0.78 LCK (1.00) LCKALDH1A1KDM4EMAPTLMNA
SCHEMBL720794 0.78 LCK (1.00) LCKALDH1A1KDM4EMAPTLMNA
SCHEMBL28799301 0.78 CCNB2 (1.00) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL974375 0.78 CCNB2 (1.00) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL690860 0.78 CCNB2 (1.00) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL31125711 0.78 CCNB2 (1.00) CCNB2CDK1CDK4CCNB1CCND1
P-Hydroxycinnamaldehyde SCHEMBL20912952 0.75 ALDH1A1 (1.00) CCNB2CDK1CDK4CCNB1CCND1
P-Hydroxycinnamaldehyde SCHEMBL196960 0.75 ALDH1A1 (1.00) CCNB2CDK1CDK4CCNB1CCND1
P-Hydroxycinnamaldehyde SCHEMBL197453 0.75 ALDH1A1 (1.00) CCNB2CDK1CDK4CCNB1CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008091555-A2 NUCLEAR RECEPTOR BINDING AGENTS GTX, INC. (US) 2008-07-31 — — WO disclosed
US-5459142-A Autoimmune disease, atherosclerosis, antiischemic agents and nephritis OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-10-17 — — US disclosed
EP-0511879-B1 Pyrazine derivatives OTSUKA PHARMA CO LTD (JP) 1995-03-22 — — EP disclosed
EP-0511879-A1 Pyrazine derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-04 — — EP disclosed
Send feedback